Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Planning and Dissemination Grant - Institute Community Support

University of British Columbia

$10,000.00

The Third Symposium on Treatment-Induced Neuroendocrine Prostate Cancer

EF 2023-24

Résumé
The Third Symposium on Treatment-Induced Neuroendocrine Prostate Cancer (NEPC) aims to gather global researchers and facilitate discussions about NEPC, a resistant subtype of prostate cancer that has seen a dramatic rise with the widespread use of androgen receptor pathway inhibitors (ARPI). This aggressive cancer urgently needs better diagnostic and treatment options. The Vancouver Prostate Centre, leaders in NEPC research, will host this two-day symposium on June 22-23, 2024. The event will include keynote speeches and discussions covering topics like NEPC diagnosis, treatment strategies, disease progression mechanisms, and patient care in the age of precision medicine. The symposium aims to promote knowledge sharing, establish collaborations, and cultivate the professional growth of emerging scientists. It will also provide opportunities for networking, which can foster new collaborations and catalyze team grant applications. Anticipated outcomes include advancements in NEPC knowledge, strengthened collaborations, enhanced scientific training, and improved patient outcomes. The symposium seeks $10,000 funding from the CIHR Planning and Dissemination Grant. This funding will support part of the speaker expenses, conference costs, travel awards, poster prizes, catering, administration, and promotion costs. We anticipate that the symposium will make significant advancements in our understanding of NEPC, drive progress in NEPC research and treatment, and share knowledge with the broader scientific community and policy makers.
Programme
Planning and Dissemination Grant - Institute Community Support
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
499305
Name
Wang Yuzhuo
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Planning and Dissemination Grants
Projecttitle
The Third Symposium on Treatment-Induced Neuroendocrine Prostate Cancer
Programtype2
Miscellaneous Programs
Orgnameinp2
University of British Columbia
Cihramount2
$10,000
Cihrequipment2
$0
Programname2
Planning and Dissemination Grant - Institute Community Support
Keyworddelim
Global Research Collaboration,; Knowledge Sharing; Neuroendocrine Prostate Cancer; Precision Medicine; Prostate Cancer; Scientific Networking; Symposium; Translational Research; Treatment Strategies; Vancouver Prostate Centre
Abstract
The Third Symposium on Treatment-Induced Neuroendocrine Prostate Cancer (NEPC) aims to gather global researchers and facilitate discussions about NEPC, a resistant subtype of prostate cancer that has seen a dramatic rise with the widespread use of androgen receptor pathway inhibitors (ARPI). This aggressive cancer urgently needs better diagnostic and treatment options. The Vancouver Prostate Centre, leaders in NEPC research, will host this two-day symposium on June 22-23, 2024. The event will include keynote speeches and discussions covering topics like NEPC diagnosis, treatment strategies, disease progression mechanisms, and patient care in the age of precision medicine. The symposium aims to promote knowledge sharing, establish collaborations, and cultivate the professional growth of emerging scientists. It will also provide opportunities for networking, which can foster new collaborations and catalyze team grant applications. Anticipated outcomes include advancements in NEPC knowledge, strengthened collaborations, enhanced scientific training, and improved patient outcomes. The symposium seeks $10,000 funding from the CIHR Planning and Dissemination Grant. This funding will support part of the speaker expenses, conference costs, travel awards, poster prizes, catering, administration, and promotion costs. We anticipate that the symposium will make significant advancements in our understanding of NEPC, drive progress in NEPC research and treatment, and share knowledge with the broader scientific community and policy makers.
Competitiondate
202402
Approvedterm2
1 yr 0 mth
Pinamesdelim
Wang, Yuzhuo
Approvedterm
1 an 0 mois
Cihrcontribution2
ICR~ $10,000~ $0~